Anti-infectives R&D

CBV has extensive experience in anti-infective R&D including viral & bacterial disease. Lloyd Czaplewski has a strong track record in generating anti-infective IP & in advancing projects through preclinical development . He is an international opinion leader working with venture capital, research councils & charities to build the case for greater investment in antibacterial translational research.

You are viewing the text version of this site.

To view the full version please install the Adobe Flash Player and ensure your web browser has JavaScript enabled.

Need help? check the requirements page.

Get Flash Player